JAK inhibitors: a promising direction for treating Rheumatoid Arthritis
<p>Rheumatoid Arthritis (RA) is a chronic auto inflammatory disease that causes incapacitating changes both the musculoskeletal system and the internal organs [1]. Tumor Necrosis Factor inhibitors (TNFi) promised a new revolutionary era in RA approximately 20 years ago. Since then, different T...
Saved in:
Main Author: | Pelechas Eleftherios (Author) |
---|---|
Format: | Book |
Published: |
International Journal of Pharmaceutical Sciences and Developmental Research - Peertechz Publications,
2017-06-09.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Rheumatoid arthritis: Treatment evolution over the years
by: Eleftherios Pelechas, et al.
Published: (2020) -
Rheumatoid Arthritis
Published: (2022) -
Rheumatoid Arthritis Treatment
Published: (2012) -
Rheumatoid Arthritis Etiology, Consequences and Co-Morbidities
Published: (2012) -
Rheumatoid Arthritis Other Perspectives towards a Better Practice
Published: (2020)